Special Issue "Marine Lipids"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (30 June 2012)

Special Issue Editor

Guest Editor
Prof. Dr. Gilles Barnathan
College of Pharmacy, University of Nantes, Nantes, France
E-Mail: gilles.barnathan@univ-nantes.fr

Special Issue Information

Dear Colleagues,

Marine lipids are undoubtly representatives of the marine chemical biodiversity. Fatty acids (FA) and lipid-containing FA are ubiquitous in nature and a number of structures occur in both terrestrial and marine organisms, but the latter organisms have proved to be a major source of unique structures. From this point of view, the most primitive animals, such as sponges and gorgonians, seem to be of great interest. Thus, in addition to the very important polyunsaturated FA such as eicosapentaenoic and docosahexaenoic acids, a great number of various FA occur in marine organisms ranged from bacteria and first planktonic marine producers to fish, including branched, non-methylene-interrupted, conjugated, hydroxylated, methoxylated and halogenated FA. These unique lipids originate from unusual biosynthetic pathways. Furthermore, oxylipins, phospholipids and glycolipids have considerable importance and will be taken into account, especially the latter compounds that excite increasing interest regarding their promising antitumor and immunomodulating activities. The biomedical potential of marine lipids leads to an intense effort of research. The chemotaxonomic value of certain lipid molecules would be also taken into account including FA and sterols.

This special issue of Marine Drugs is devoted to “Marine Lipids”. The aim of this issue is to present the recent advances and to introduce some important future research directions in the field of research. Thus, we hope that the manuscripts here included will cover a number of aspects of recent developments within this field.

Prof. Dr. Gilles Barnathan
Guest Editor

Keywords

  • lipids
  • glycolipids
  • phospholipids
  • oxylipins
  • fatty acids
  • sterols
  • marine organisms
  • algae
  • marine chemical ecology
  • biosynthetic pathways
  • biomarkers
  • biological interest
  • biological activity

Published Papers (12 papers)

Mar. Drugs 2013, 11(4), 1304-1315; doi:10.3390/md11041304
Received: 6 February 2013; in revised form: 4 March 2013 / Accepted: 19 March 2013 / Published: 17 April 2013
Show/Hide Abstract | Download PDF Full-text (525 KB) | View HTML Full-text | Download XML Full-text |  Supplementary Files

Mar. Drugs 2012, 10(12), 2846-2860; doi:10.3390/md10122846
Received: 11 September 2012; in revised form: 19 November 2012 / Accepted: 3 December 2012 / Published: 14 December 2012
Show/Hide Abstract | Download PDF Full-text (927 KB) | View HTML Full-text | Download XML Full-text |  Supplementary Files
abstract graphic

Mar. Drugs 2012, 10(12), 2698-2714; doi:10.3390/md10122698
Received: 8 October 2012; in revised form: 14 November 2012 / Accepted: 22 November 2012 / Published: 29 November 2012
Show/Hide Abstract | Download PDF Full-text (503 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2012, 10(12), 2676-2690; doi:10.3390/md10122676
Received: 9 October 2012; in revised form: 12 November 2012 / Accepted: 15 November 2012 / Published: 26 November 2012
Show/Hide Abstract | Download PDF Full-text (647 KB) | View HTML Full-text | Download XML Full-text
abstract graphic

Mar. Drugs 2012, 10(11), 2535-2559; doi:10.3390/md10112535
Received: 24 September 2012; in revised form: 16 October 2012 / Accepted: 31 October 2012 / Published: 13 November 2012
Show/Hide Abstract | Download PDF Full-text (300 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2012, 10(9), 2047-2054; doi:10.3390/md10092047
Received: 3 August 2012; in revised form: 23 August 2012 / Accepted: 5 September 2012 / Published: 20 September 2012
Show/Hide Abstract | Download PDF Full-text (326 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2012, 10(9), 1920-1935; doi:10.3390/md10091920
Received: 10 July 2012; in revised form: 6 August 2012 / Accepted: 14 August 2012 / Published: 24 August 2012
Show/Hide Abstract | Download PDF Full-text (849 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2010, 8(12), 2988-2998; doi:10.3390/md8122988
Received: 5 November 2010; in revised form: 6 December 2010 / Accepted: 20 December 2010 / Published: 22 December 2010
Show/Hide Abstract | Download PDF Full-text (332 KB) | View HTML Full-text | Download XML Full-text
abstract graphic

Mar. Drugs 2010, 8(12), 2961-2975; doi:10.3390/md8122961
Received: 21 October 2010; in revised form: 13 December 2010 / Accepted: 16 December 2010 / Published: 17 December 2010
Show/Hide Abstract | Download PDF Full-text (357 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2010, 8(10), 2597-2604; doi:10.3390/md8102597
Received: 2 September 2010; in revised form: 27 September 2010 / Accepted: 28 September 2010 / Published: 8 October 2010
Show/Hide Abstract | Download PDF Full-text (327 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2010, 8(10), 2569-2577; doi:10.3390/md8102569
Received: 7 September 2010; in revised form: 27 September 2010 / Accepted: 30 September 2010 / Published: 8 October 2010
Show/Hide Abstract | Download PDF Full-text (113 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2010, 8(7), 2175-2184; doi:10.3390/md8072175
Received: 7 June 2010; in revised form: 7 July 2010 / Accepted: 14 July 2010 / Published: 19 July 2010
Show/Hide Abstract | Download PDF Full-text (89 KB) | View HTML Full-text | Download XML Full-text

Last update: 27 February 2014

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert